These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 26242257)
1. Flavonoids and Related Compounds in Non-Alcoholic Fatty Liver Disease Therapy. Pisonero-Vaquero S; González-Gallego J; Sánchez-Campos S; García-Mediavilla MV Curr Med Chem; 2015; 22(25):2991-3012. PubMed ID: 26242257 [TBL] [Abstract][Full Text] [Related]
2. The potential of flavonoids in the treatment of non-alcoholic fatty liver disease. Van De Wier B; Koek GH; Bast A; Haenen GR Crit Rev Food Sci Nutr; 2017 Mar; 57(4):834-855. PubMed ID: 25897647 [TBL] [Abstract][Full Text] [Related]
4. Hepatoprotective Effect of Loquat Leaf Flavonoids in PM Jian T; Ding X; Wu Y; Ren B; Li W; Lv H; Chen J Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30275422 [TBL] [Abstract][Full Text] [Related]
5. Non-alcoholic fatty liver disease and flavonoids: Current perspectives. Shin JH; Jung JH Clin Res Hepatol Gastroenterol; 2017 Feb; 41(1):17-24. PubMed ID: 27545758 [TBL] [Abstract][Full Text] [Related]
6. Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review. Bagherniya M; Nobili V; Blesso CN; Sahebkar A Pharmacol Res; 2018 Apr; 130():213-240. PubMed ID: 29287685 [TBL] [Abstract][Full Text] [Related]
7. Prevention and treatment effect of total flavonoids in Stellera chamaejasme L. on nonalcoholic fatty liver in rats. Wang Y; Li JY; Han M; Wang WL; Li YZ Lipids Health Dis; 2015 Aug; 14():85. PubMed ID: 26242978 [TBL] [Abstract][Full Text] [Related]
8. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice. Lee MR; Yang HJ; Park KI; Ma JY Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424 [TBL] [Abstract][Full Text] [Related]
10. Silibinin Capsules improves high fat diet-induced nonalcoholic fatty liver disease in hamsters through modifying hepatic de novo lipogenesis and fatty acid oxidation. Cui CX; Deng JN; Yan L; Liu YY; Fan JY; Mu HN; Sun HY; Wang YH; Han JY J Ethnopharmacol; 2017 Aug; 208():24-35. PubMed ID: 28648927 [TBL] [Abstract][Full Text] [Related]
11. The great potential of flavonoids as candidate drugs for NAFLD. Li L; Qin Y; Xin X; Wang S; Liu Z; Feng X Biomed Pharmacother; 2023 Aug; 164():114991. PubMed ID: 37302319 [TBL] [Abstract][Full Text] [Related]
12. Hepatoprotective effect of herb formula KIOM2012H against nonalcoholic fatty liver disease. Park H; Hwang YH; Kim DG; Jeon J; Ma JY Nutrients; 2015 Apr; 7(4):2440-55. PubMed ID: 25849950 [TBL] [Abstract][Full Text] [Related]
13. Preventive Effect of Citrus aurantium Peel Extract on High-Fat Diet-Induced Non-alcoholic Fatty Liver in Mice. Han HY; Lee SK; Choi BK; Lee DR; Lee HJ; Kim TW Biol Pharm Bull; 2019; 42(2):255-260. PubMed ID: 30713255 [TBL] [Abstract][Full Text] [Related]
14. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice. Liou CJ; Wei CH; Chen YL; Cheng CY; Wang CL; Huang WC Cell Physiol Biochem; 2018; 49(5):1870-1884. PubMed ID: 30235452 [TBL] [Abstract][Full Text] [Related]
15. Polyphenols and non-alcoholic fatty liver disease: impact and mechanisms. Rodriguez-Ramiro I; Vauzour D; Minihane AM Proc Nutr Soc; 2016 Feb; 75(1):47-60. PubMed ID: 26592314 [TBL] [Abstract][Full Text] [Related]
16. Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Takahashi Y; Sugimoto K; Inui H; Fukusato T World J Gastroenterol; 2015 Apr; 21(13):3777-85. PubMed ID: 25852263 [TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic fatty liver disease and its treatment with n-3 polyunsaturated fatty acids. de Castro GS; Calder PC Clin Nutr; 2018 Feb; 37(1):37-55. PubMed ID: 28139281 [TBL] [Abstract][Full Text] [Related]
18. Green tea polyphenols ameliorate non-alcoholic fatty liver disease through upregulating AMPK activation in high fat fed Zucker fatty rats. Tan Y; Kim J; Cheng J; Ong M; Lao WG; Jin XL; Lin YG; Xiao L; Zhu XQ; Qu XQ World J Gastroenterol; 2017 Jun; 23(21):3805-3814. PubMed ID: 28638220 [TBL] [Abstract][Full Text] [Related]
19. Novel Action of Carotenoids on Non-Alcoholic Fatty Liver Disease: Macrophage Polarization and Liver Homeostasis. Ni Y; Zhuge F; Nagashimada M; Ota T Nutrients; 2016 Jun; 8(7):. PubMed ID: 27347998 [TBL] [Abstract][Full Text] [Related]
20. n-3 Fatty acids combined with flavan-3-ols prevent steatosis and liver injury in a murine model of NAFLD. Vauzour D; Rodriguez-Ramiro I; Rushbrook S; Ipharraguerre IR; Bevan D; Davies S; Tejera N; Mena P; de Pascual-Teresa S; Del Rio D; Gavrilovic J; Minihane AM Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):69-78. PubMed ID: 28986308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]